PMDD and Suicidal Thoughts: Why the Risk Peaks Before Your Period

PMDD and suicidal thoughts are linked far more tightly than most people, and many clinicians, realize. The risk concentrates in the days before menses, which shapes how it’s treated.

This guide covers why the risk climbs in the luteal phase and what lowers it. It’s a companion to my main guide on PMDD treatment and why it isn’t a hormone imbalance. If you want an evaluation rather than an explanation, you can book a consultation.

If you are still sorting out whether this is PMDD at all, see PMDD vs PMS and premenstrual exacerbation.

How closely PMDD and suicidal thoughts are linked

In the largest sample of people whose PMDD was confirmed by a clinician using two cycles of daily ratings, rather than a single recalled questionnaire, the lifetime rates were high. 72 percent reported active suicidal ideation, 49 percent had made a plan, and 34 percent had attempted suicide (PMID: 35303811).

A meta-analysis of six studies and more than 8,000 women found PMDD roughly doubled the odds of both suicidal ideation and suicide attempts (PMID: 34488087). Measured during the late luteal phase specifically, about 39 percent of women with PMDD reported current suicidal ideation (PMID: 35148753), a rate near that seen in major depression.

One caveat about that sample: 70 percent also carried another psychiatric diagnosis, so PMDD rarely travels alone. A PMDD assessment should evaluate the entire clinical picture and establish whether any comorbidities are present.

Why the risk climbs before your period

PMDD is a sensitivity to the normal hormone shifts of a normal cycle. The brain’s GABA-A system responds abnormally to the progesterone metabolite allopregnanolone as it rises and falls, and the trigger is that shift in steroid levels rather than any abnormal level (PMID: 9435325). I cover the mechanism in depth in the main PMDD guide.

Suicidal thinking appears to follow the same pattern. In a daily-diary study of female outpatients with a history of suicidality, the risk of suicidal ideation and planning rose in the days surrounding menstruation, across diagnoses, not only in women with PMDD (PMID: 38093647). For many women the perimenstrual phase is a high-risk window, and PMDD is its most severe form.

The thoughts that show up in the late luteal days are state-dependent. They track the cycle and tend to lift once bleeding starts. They reflect a temporary hormonal state, and that state passes.

Planning around the high-risk days

Because PMDD follows the cycle, the highest-risk days tend to fall in the same part of each month, which means they can be anticipated.

The two cycles of daily ratings that confirm the diagnosis also show when the risk peaks. Once you and your clinician can see which days carry it, you can plan for them: schedule support and lighter obligations into those days, and reduce access to lethal means during that window. A safety plan tied to specific dates gives you and your clinician something concrete to act on.

Treatments that bring the risk down

Treating PMDD is the way to lower the suicidality that comes with it, since the thoughts are driven by the disorder. SSRIs are first-line, and the evidence for reducing premenstrual symptoms is strong (PMID: 23744611). In PMDD they often work within a day or two rather than the weeks they take in depression, which makes luteal-phase dosing, taking the medication only during the symptomatic window, a legitimate option. I walk through the dosing schedules in the main PMDD guide.

Where comorbidity is part of the picture, and it usually is, that condition gets its own treatment rather than being folded into the PMDD plan. Non-drug measures have a place too. Cognitive behavioral therapy holds up about as well as medication for the mood symptoms, and a few supplements have real evidence, which I grade in the companion piece on natural treatments for PMDD. None of these substitute for medical care when the luteal week brings suicidal thoughts.

The same skepticism I bring to the chemical imbalance story in depression cuts both ways: when a drug has good evidence, using it is the honest move, and SSRIs for PMDD have that evidence.

What to do if you’re in the window right now

If you’re reading this in your luteal days and the thoughts are loud, the first job is getting through the window safely. Everything else can wait. Call or text 988. Tell one person you trust what’s happening. Put distance between yourself and any means of harm, and ask someone to help you do it. The thoughts that feel permanent right now are tied to a phase that will pass.

If you’re in immediate danger, that’s an emergency, and it belongs with 911 or an emergency room. Booking an evaluation is the right step for the ongoing pattern, once you’re safe in the moment.

When it’s a premenstrual flare of another condition

Because most people with PMDD carry another diagnosis, the assessment has to separate true PMDD from a premenstrual exacerbation of something else. Bipolar disorder, major depression, PTSD, and borderline personality disorder can all intensify in the luteal phase, and the suicidality that comes with them does too. The difference is whether the symptoms clear after the period or run all month at a lower level.

That distinction changes the plan. A premenstrual flare of bipolar disorder needs the bipolar treated, not a PMDD protocol. Getting it wrong in either direction leaves the real driver of the risk unaddressed, which is exactly why the daily tracking matters before anyone commits to a diagnosis.

How I approach this in my North Carolina telehealth practice

My role is the ongoing, cyclical risk: evaluating whether it’s truly PMDD, treating it, and building safety planning around your window. We start with two cycles of daily ratings, which both confirm the diagnosis and show us where the dangerous days fall. From there, treatment is usually an SSRI dosed luteally or continuously, with comorbid conditions treated in their own right, and a safety plan keyed to the calendar.

I want to be clear about the limit of telehealth here. An acute crisis, with active intent or a plan, belongs with 988 or an emergency room in the moment. What I manage is the recurring pattern between those moments, the part that responds to getting the diagnosis and treatment right. If anxiety runs alongside the cyclical symptoms, my work on treating anxiety in North Carolina is relevant to how I’d structure care.

Frequently asked questions

Can PMDD cause suicidal thoughts?

Yes. Suicidal thoughts are common in PMDD, and they tend to concentrate in the days before the period. In the largest clinician-confirmed sample, 72 percent reported lifetime active suicidal ideation and 34 percent had attempted suicide (PMID: 35303811). If you’re having these thoughts now, call or text 988 to reach the Suicide and Crisis Lifeline.

Why are my suicidal thoughts worse right before my period?

The luteal phase is a higher-risk window. PMDD reflects a brain sensitivity to the normal hormone shifts of the cycle, and suicidal ideation and planning tend to rise in the days surrounding menstruation, even across other diagnoses (PMID: 38093647). The thoughts are state-dependent and usually ease once bleeding starts, which is part of why tracking the pattern is so useful.

Does treating PMDD reduce the suicidal thoughts?

Treating the disorder is the route to lowering the risk that comes with it. SSRIs reduce premenstrual symptoms and often work within a day or two in PMDD, which allows luteal-phase dosing for some women. Where another condition is also present, it needs its own treatment. None of this replaces immediate crisis support when thoughts are acute.

Should I use telehealth or go to the emergency room?

If you’re in acute crisis, with active intent or a plan, that’s an emergency: call or text 988, call 911, or go to an emergency room. Telehealth is the right setting for the ongoing, recurring pattern, evaluating and treating PMDD and building a safety plan around your cycle, once you’re safe in the moment.

This article is for educational purposes only and is not medical advice. It does not create a physician-patient relationship. PMDD and suicidality require individual evaluation, and treatment should be directed by your own clinician. Do not start, stop, or change any medication without consulting your prescribing clinician. If you are in crisis or thinking about harming yourself, call or text 988 in the United States to reach the Suicide and Crisis Lifeline, or call 911 in an emergency.

References

1. Eisenlohr-Moul T, Divine M, Schmalenberger K, et al. Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder. BMC Psychiatry. 2022;22(1):199. PMID: 35303811.
2. Yan H, Ding Y, Guo W. Suicidality in patients with premenstrual dysphoric disorder: a systematic review and meta-analysis. J Affect Disord. 2021;295:339-346. PMID: 34488087.
3. Wikman A, Sacher J, Bixo M, et al. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder. BMC Womens Health. 2022;22(1):35. PMID: 35148753.
4. Ross JM, Barone JC, Tauseef H, et al. Predicting acute changes in suicidal ideation and planning: a longitudinal study of symptom mediators and the role of the menstrual cycle in female psychiatric outpatients with suicidality. Am J Psychiatry. 2024;181(1):57-67. PMID: 38093647.
5. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338(4):209-216. PMID: 9435325.
6. Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;(6):CD001396. PMID: 23744611.
7. Bixo M, Ekberg K, Sundström Poromaa I, et al. Treatment of premenstrual dysphoric disorder with the GABA-A receptor modulating steroid antagonist sepranolone (UC1010): a randomized controlled trial. Psychoneuroendocrinology. 2017;80:46-55. PMID: 28319848.